Omalizumab is well tolerated in adolescent/adult patients...

Journal of Allergy and Clinical Immunology 2005 / 2 Vol. 115; Iss. 2

Omalizumab is well tolerated in adolescent/adult patients (≥12 Years) with moderate-to-severe persistent asthma

Corren, J., Casale, T., Lanier, B.Q., Blogg, M., Reisner, C., Gupta, N.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
115
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2004.12.314
Date:
February, 2005
File:
PDF, 29 KB
english, 2005
Conversion to is in progress
Conversion to is failed